Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

Abstract Background The impact of direct-acting antivirals (DAAs) remains a debate, whether they accelerate the recurrence rate of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) after curative therapy. We evaluated the impact of direct-acting antiviral therapy on the rate of recurren...

Full description

Bibliographic Details
Main Authors: Nevine Ibrahim Musa, Inas Elkhedr Mohamed, Ahmed Samir Abohalima
Format: Article
Language:English
Published: SpringerOpen 2020-07-01
Series:Egyptian Liver Journal
Subjects:
Hepatocellular carcinoma
Direct-acting antivirals
Hepatitis C virus
Online Access:http://link.springer.com/article/10.1186/s43066-020-00035-x

Internet

http://link.springer.com/article/10.1186/s43066-020-00035-x

Similar Items